| Primary |
| Gout |
33.3% |
| Product Used For Unknown Indication |
24.5% |
| Allergy Prophylaxis |
21.1% |
| Gouty Tophus |
6.1% |
| Pain |
3.5% |
| Premedication |
2.9% |
| Hypertension |
2.5% |
| Pulmonary Hypertension |
1.0% |
| Diabetes Mellitus |
0.8% |
| Drug Use For Unknown Indication |
0.8% |
| Arthralgia |
0.3% |
| Asthma |
0.3% |
| Blood Pressure |
0.3% |
| Cardiac Disorder |
0.3% |
| Cardiac Failure Congestive |
0.3% |
| Cellulitis |
0.3% |
| Coronary Artery Disease |
0.3% |
| Gouty Arthritis |
0.3% |
| Nausea |
0.3% |
| Osteoporosis |
0.3% |
|
| Therapeutic Response Decreased |
29.6% |
| Infusion Related Reaction |
24.3% |
| Gout |
13.2% |
| Anaphylactic Reaction |
7.9% |
| Condition Aggravated |
2.6% |
| Blood Creatinine Increased |
2.0% |
| Dyspnoea |
2.0% |
| Haematocrit Decreased |
2.0% |
| Malaise |
2.0% |
| Anaphylactic Shock |
1.3% |
| Arthralgia |
1.3% |
| Cardiac Failure Congestive |
1.3% |
| Death |
1.3% |
| Drug Ineffective |
1.3% |
| Haemolysis |
1.3% |
| Hypersensitivity |
1.3% |
| Methaemoglobinaemia |
1.3% |
| Myocardial Infarction |
1.3% |
| Pain |
1.3% |
| Pruritus |
1.3% |
|
| Secondary |
| Gout |
32.8% |
| Allergy Prophylaxis |
31.7% |
| Product Used For Unknown Indication |
20.3% |
| Premedication |
3.8% |
| Pain |
2.3% |
| Hypertension |
1.9% |
| Drug Use For Unknown Indication |
1.3% |
| Gouty Tophus |
1.3% |
| Diabetes Mellitus |
1.1% |
| Blood Pressure Abnormal |
0.7% |
| Renal Failure Chronic |
0.5% |
| Cardiac Disorder |
0.4% |
| Hyperlipidaemia |
0.3% |
| Arthralgia |
0.2% |
| Asthma |
0.2% |
| Blood Pressure |
0.2% |
| Cellulitis |
0.2% |
| Coronary Artery Disease |
0.2% |
| Hypothyroidism |
0.2% |
| Lyme Disease |
0.2% |
|
| Therapeutic Response Decreased |
43.8% |
| Infusion Related Reaction |
14.6% |
| Gout |
4.2% |
| Renal Failure |
4.2% |
| Renal Failure Acute |
4.2% |
| Fatigue |
3.1% |
| Sudden Death |
3.1% |
| Unresponsive To Stimuli |
3.1% |
| Anaphylactic Reaction |
2.1% |
| Cardiac Failure Congestive |
2.1% |
| Coronary Artery Disease |
2.1% |
| Haematocrit Decreased |
2.1% |
| Haemolysis |
2.1% |
| Liver Function Test Abnormal |
2.1% |
| Weight Increased |
2.1% |
| Chest Pain |
1.0% |
| Diabetes Mellitus |
1.0% |
| Hepatocellular Injury |
1.0% |
| Hypersensitivity |
1.0% |
| Ocular Hyperaemia |
1.0% |
|
| Concomitant |
| Blood Pressure Abnormal |
45.0% |
| Gout |
40.0% |
| Gouty Tophus |
7.5% |
| Diabetes Mellitus |
5.0% |
| Back Pain |
2.5% |
|
| Renal Failure Acute |
54.5% |
| Hepatotoxicity |
27.3% |
| Cerebrovascular Accident |
9.1% |
| Urticaria |
9.1% |
|
